Cardiff Oncology, Inc. (Nasdaq: CRDF), a clinical-stage biotechnology company leveraging PLK1 inhibition to develop novel therapies across a range of cancers, today announced that the Company will ...
Finding new ways in the approach to colorectal cancer is therefore fundamental. And there is no shortage of good news. Italy is the first country in Europe to guarantee, through the National Health ...
Explore the latest colorectal cancer treatment advances, from precision oncology and immunotherapy to ADCs, bispecifics, and ...
It isn’t clear what’s driving the shift, but scientists suspect that environmental exposures may be partially to blame. By Nina Agrawal Nearly half of all new colorectal cancer cases now occur in ...
The FDA granted full approval to Braftovi (encorafenib) in combination with cetuximab and fluorouracil-based chemotherapy for adult patients with metastatic colorectal cancer (mCRC) harboring a BRAF ...
The FDA has granted traditional approval to encorafenib (Braftovi, Pfizer) in combination with cetuximab (Erbitux, Eli Lilly) and fluorouracil-based chemotherapy for treatment of adults with ...
Pfizer Inc. (NYSE: PFE) today announced that the U.S. Food and Drug Administration (FDA) has granted full approval to ...
The BRAFTOVI combination regimen is the only approved targeted regimen for first-line BRAF-V600E mutant metastatic colorectal cancer Pivotal results from the Phase 3 portion with mFOLFOX6 of the ...
Traditional FDA approval covers encorafenib plus cetuximab with fluorouracil-based chemotherapy for adult metastatic CRC with BRAF V600E mutations confirmed by an FDA-authorized test. BREAKWATER ...
Add Yahoo as a preferred source to see more of our stories on Google. Researchers from the University of Southern Denmark have identified a new virus that appears to be linked to colon cancer. The ...
Some types of cancer, such as cervical, breast, and prostate cancer, are easy to catch early. Tests and screenings exist that help doctors detect these illnesses and take potentially life-saving ...